Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell DiseaseGuoyan Xu, Osheiza Abdulmalik, Faik N. Musayev et al.|Molecular Pharmaceutics|2017Cited by 55
VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditionsOsheiza Abdulmalik, Martin K. Safo, Piyusha P. Pagare et al.|Scientific Reports|2020Cited by 25
Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin–NO BiochemistryGuoyan Xu, Martin K. Safo, Tanvi Deshpande et al.|Biochemistry|2015Cited by 12
Vzhe-039, a Novel Structurally-Enhanced Allosteric Hemoglobin Effector Inhibits Sickling of SS Erythrocytes In Vitro, and Exhibits Improved Pharmacologic Properties In VivoMartin K. Safo, Osheiza Abdulmalik, Guoyan Xu et al.|Blood|2016Cited by 2